A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2094034
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine in a randomized, placebo-controlled, phase II trial if the combination of sulindac and erlotinib causes a significant regression of duodenal and colorectal adenomas in familial adenomatous polyposis (FAP) and attenuated FAP (AFAP) patients.
创建时间：
2010-04-15
